Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima

Descripción del Articulo

DESIGN: This multicentric prospective, double-blind study compared the safety and efficacy of clindamvcin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients wild mild to moderate pelvic inflammatory disease, diagnosed through laparoscopy. MATERIAL AND METHODS: Prior...

Descripción completa

Detalles Bibliográficos
Autores: Díaz, Víctor, Maradiegue, Eduardo, Escudero, Francisco, Sa, Pedro
Formato: artículo
Fecha de Publicación:2015
Institución:Sociedad Peruana de Obstetricia y Ginecología
Repositorio:Revista SPOG - Revista Peruana de Ginecología y Obstetricia
Lenguaje:español
OAI Identifier:oai:ojs.spog:article/982
Enlace del recurso:http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982
Nivel de acceso:acceso abierto
id 2304-5132_f257d7b0697ff13980ec6aa3018c4477
oai_identifier_str oai:ojs.spog:article/982
network_acronym_str 2304-5132
repository_id_str .
network_name_str Revista SPOG - Revista Peruana de Ginecología y Obstetricia
spelling Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in LimaTratamiento oral de clindamicina y ciprofloxacina versus ceftriaxona intramuscular y doxiciclina oral t el tratamiento ambulatorio de la enfermedad pélvica inflamatoria leve a moderada en dos Hospitales de LimaDíaz, VíctorMaradiegue, EduardoEscudero, FranciscoSa, PedroDESIGN: This multicentric prospective, double-blind study compared the safety and efficacy of clindamvcin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients wild mild to moderate pelvic inflammatory disease, diagnosed through laparoscopy. MATERIAL AND METHODS: Prior to the treatment, samples were taken from endocervix, endometrium, abdominal cavity, and in cases with positive cultures to aerobes and anaerohes, Neisseria gonorrhoeae and Chlamydia trachomatis. From the total of 65 patients enrolled, 63 were evaluated for efficacy. RESULTS: The prevalent bacteriae were staphylococcus and streptococcus (among aerobes) and peptostreptococcus and bacteroids (among anaerobes). N. gonorrhoeae was present in 1, 8% (1) of the 53 evaluable patients and c. trachomatis in 9,4% (5). Clinical cure was 85,7% (24 from 28) in the clindamycin plus ciprofloxacin group and 68% (17 from 25) in the ceftriaxone plus doxycycline group. CONCLUSIONS: Both treatment regimens for outpatients with, mild to moderate PID were similar in effectivity and safety.DISEÑO: Este estudio multicéntrico, prospectivo, doble ciego, comparó la seguridad y eficacia de clindamicina y ciprofloxacina versus ceftriaxona y doxiciclina en el tratamiento de pacientes ambulatorios con enfermedad inflamatoria pélvica (EIP) leve a moderada diagnosticada laparoscópicamente. MATERIAL Y METODOS: Se tomó muestras del endocérvix, endometrio y cavidad abdominal antes del tratamiento y en los casos con cultivos positivos a aerobios, anaerobios, Neisseria gonorrhoeae y Chlamydia trachomatis. De las 65pacientes enroladas, 63 fueron evaluables para eficacia. RESULTADOS: Las bacterias más prevalentes fueron esta filocos y estreptococos (entre aerobios) y peptoestreptococos y bacteroides (entre N. gonorrhoeae estuvo presente en 1, 8% (1) las 53pacientes evaluables y C. trachomatis en el 9,4% (5). La cura clínica fue de 85,7% (24 de 28) en el grupo de clindamicina y ciprofloxacina y 68% (17 de 25) en el grupo de ceftriaxona doxiciclina. CONCLUSION.- Los dos regímenes de tratamiento para pacientes ambulatorias con EIP leve a moderada fueron similarmente efectivos y seguros.Sociedad Peruana de Obstetricia y Ginecología2015-06-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://www.spog.org.pe/web/revista/index.php/RPGO/article/view/98210.31403/rpgo.v44i982Revista Peruana de Ginecología y Obstetricia; Vol. 44, Núm. 1 (1998); 21-272304-51322304-5124reponame:Revista SPOG - Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspahttp://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982/944info:eu-repo/semantics/openAccess2021-05-31T15:51:49Zmail@mail.com -
dc.title.none.fl_str_mv Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
Tratamiento oral de clindamicina y ciprofloxacina versus ceftriaxona intramuscular y doxiciclina oral t el tratamiento ambulatorio de la enfermedad pélvica inflamatoria leve a moderada en dos Hospitales de Lima
title Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
spellingShingle Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
Díaz, Víctor
title_short Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
title_full Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
title_fullStr Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
title_full_unstemmed Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
title_sort Oral treatment of clindamycin and ciprofloxacin vs intramuscular ceftriaxone and oral doxycycline t outpatient treatment of mild to moderate pelvic inflammatory disease in two hospitals in Lima
dc.creator.none.fl_str_mv Díaz, Víctor
Maradiegue, Eduardo
Escudero, Francisco
Sa, Pedro
author Díaz, Víctor
author_facet Díaz, Víctor
Maradiegue, Eduardo
Escudero, Francisco
Sa, Pedro
author_role author
author2 Maradiegue, Eduardo
Escudero, Francisco
Sa, Pedro
author2_role author
author
author
dc.contributor.none.fl_str_mv

dc.description.none.fl_txt_mv DESIGN: This multicentric prospective, double-blind study compared the safety and efficacy of clindamvcin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients wild mild to moderate pelvic inflammatory disease, diagnosed through laparoscopy. MATERIAL AND METHODS: Prior to the treatment, samples were taken from endocervix, endometrium, abdominal cavity, and in cases with positive cultures to aerobes and anaerohes, Neisseria gonorrhoeae and Chlamydia trachomatis. From the total of 65 patients enrolled, 63 were evaluated for efficacy. RESULTS: The prevalent bacteriae were staphylococcus and streptococcus (among aerobes) and peptostreptococcus and bacteroids (among anaerobes). N. gonorrhoeae was present in 1, 8% (1) of the 53 evaluable patients and c. trachomatis in 9,4% (5). Clinical cure was 85,7% (24 from 28) in the clindamycin plus ciprofloxacin group and 68% (17 from 25) in the ceftriaxone plus doxycycline group. CONCLUSIONS: Both treatment regimens for outpatients with, mild to moderate PID were similar in effectivity and safety.
DISEÑO: Este estudio multicéntrico, prospectivo, doble ciego, comparó la seguridad y eficacia de clindamicina y ciprofloxacina versus ceftriaxona y doxiciclina en el tratamiento de pacientes ambulatorios con enfermedad inflamatoria pélvica (EIP) leve a moderada diagnosticada laparoscópicamente. MATERIAL Y METODOS: Se tomó muestras del endocérvix, endometrio y cavidad abdominal antes del tratamiento y en los casos con cultivos positivos a aerobios, anaerobios, Neisseria gonorrhoeae y Chlamydia trachomatis. De las 65pacientes enroladas, 63 fueron evaluables para eficacia. RESULTADOS: Las bacterias más prevalentes fueron esta filocos y estreptococos (entre aerobios) y peptoestreptococos y bacteroides (entre N. gonorrhoeae estuvo presente en 1, 8% (1) las 53pacientes evaluables y C. trachomatis en el 9,4% (5). La cura clínica fue de 85,7% (24 de 28) en el grupo de clindamicina y ciprofloxacina y 68% (17 de 25) en el grupo de ceftriaxona doxiciclina. CONCLUSION.- Los dos regímenes de tratamiento para pacientes ambulatorias con EIP leve a moderada fueron similarmente efectivos y seguros.
description DESIGN: This multicentric prospective, double-blind study compared the safety and efficacy of clindamvcin and ciprofloxacin versus ceftriaxone and doxycycline in the treatment of outpatients wild mild to moderate pelvic inflammatory disease, diagnosed through laparoscopy. MATERIAL AND METHODS: Prior to the treatment, samples were taken from endocervix, endometrium, abdominal cavity, and in cases with positive cultures to aerobes and anaerohes, Neisseria gonorrhoeae and Chlamydia trachomatis. From the total of 65 patients enrolled, 63 were evaluated for efficacy. RESULTS: The prevalent bacteriae were staphylococcus and streptococcus (among aerobes) and peptostreptococcus and bacteroids (among anaerobes). N. gonorrhoeae was present in 1, 8% (1) of the 53 evaluable patients and c. trachomatis in 9,4% (5). Clinical cure was 85,7% (24 from 28) in the clindamycin plus ciprofloxacin group and 68% (17 from 25) in the ceftriaxone plus doxycycline group. CONCLUSIONS: Both treatment regimens for outpatients with, mild to moderate PID were similar in effectivity and safety.
publishDate 2015
dc.date.none.fl_str_mv 2015-06-19
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982
10.31403/rpgo.v44i982
url http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982
identifier_str_mv 10.31403/rpgo.v44i982
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/982/944
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
dc.source.none.fl_str_mv Revista Peruana de Ginecología y Obstetricia; Vol. 44, Núm. 1 (1998); 21-27
2304-5132
2304-5124
reponame:Revista SPOG - Revista Peruana de Ginecología y Obstetricia
instname:Sociedad Peruana de Obstetricia y Ginecología
instacron:SPOG
reponame_str Revista SPOG - Revista Peruana de Ginecología y Obstetricia
collection Revista SPOG - Revista Peruana de Ginecología y Obstetricia
instname_str Sociedad Peruana de Obstetricia y Ginecología
instacron_str SPOG
institution SPOG
repository.name.fl_str_mv -
repository.mail.fl_str_mv mail@mail.com
_version_ 1701289838719795200
score 13.982926
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).